Overview

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

Status:
Completed
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
Primarily, this clinical investigation compared overall survival and recurrence-free survival in patients with hormone receptor-negative breast cancer treated with pre- and postoperative chemotherapy vs. conventional postoperative treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Austrian Breast & Colorectal Cancer Study Group
Treatments:
Cyclophosphamide
Epirubicin
Fluorouracil
Methotrexate